62 related articles for article (PubMed ID: 12766899)
1. Contrast-enhanced MR angiography of the run-off vasculature: intraindividual comparison of gadobenate dimeglumine with gadopentetate dimeglumine.
Knopp MV; Giesel FL; von Tengg-Kobligk H; Radeleff J; Requardt M; Kirchin MA; Hentrich HR
J Magn Reson Imaging; 2003 Jun; 17(6):694-702. PubMed ID: 12766899
[TBL] [Abstract][Full Text] [Related]
2. T1 mapping of the myocardium: intra-individual assessment of post-contrast T1 time evolution and extracellular volume fraction at 3T for Gd-DTPA and Gd-BOPTA.
Kawel N; Nacif M; Zavodni A; Jones J; Liu S; Sibley CT; Bluemke DA
J Cardiovasc Magn Reson; 2012 Apr; 14(1):26. PubMed ID: 22540153
[TBL] [Abstract][Full Text] [Related]
3. Dynamic and static magnetic resonance angiography of the supra-aortic vessels at 3.0 T: intraindividual comparison of gadobutrol, gadobenate dimeglumine, and gadoterate meglumine at equimolar dose.
Kramer JH; Arnoldi E; François CJ; Wentland AL; Nikolaou K; Wintersperger BJ; Grist TM
Invest Radiol; 2013 Mar; 48(3):121-8. PubMed ID: 23211552
[TBL] [Abstract][Full Text] [Related]
4. T1 mapping of the myocardium: intra-individual assessment of the effect of field strength, cardiac cycle and variation by myocardial region.
Kawel N; Nacif M; Zavodni A; Jones J; Liu S; Sibley CT; Bluemke DA
J Cardiovasc Magn Reson; 2012 May; 14(1):27. PubMed ID: 22548832
[TBL] [Abstract][Full Text] [Related]
5. Data mining and analysis of the adverse events derived signals of 4 gadolinium-based contrast agents based on the US Food and drug administration adverse event reporting system.
Wang L; Wang Y; Zhao Q
Expert Opin Drug Saf; 2024 Mar; 23(3):339-352. PubMed ID: 37837355
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the Contrast Enhancement Performance of Gadopiclenol for Magnetic Resonance Angiography in Healthy Rabbits and Pigs.
Hugon G; Adriaensen H; Wintrebert M; Arnould L; Serfaty JM; Robert P
Invest Radiol; 2024 May; ():. PubMed ID: 38709660
[TBL] [Abstract][Full Text] [Related]
7. Stability testing of gadoteridol and gadobenate dimeglumine formulations under exposure to high-intensity focused ultrasound.
Colombo Serra S; Gaud E; Bano E; Bicocchi G; Bruno E; Tedoldi F
Br J Radiol; 2022 Dec; 95(1140):20220619. PubMed ID: 36169642
[TBL] [Abstract][Full Text] [Related]
8. A cell-penetrating protein designed for bimodal fluorescence and magnetic resonance imaging.
Wu Q; Cheng Q; Yuan S; Qian J; Zhong K; Qian Y; Liu Y
Chem Sci; 2015 Nov; 6(11):6607-6613. PubMed ID: 28757964
[TBL] [Abstract][Full Text] [Related]
9. Contrast-enhanced MR angiography: does a higher relaxivity MR contrast agent permit a reduction of the dose administered for routine vascular imaging applications?
Xing X; Zeng X; Li X; Zhao Q; Kirchin MA; Pirovano G; Wang X; Li Y; Iezzi R; De Cobelli F
Radiol Med; 2015 Feb; 120(2):239-50. PubMed ID: 25183340
[TBL] [Abstract][Full Text] [Related]
10. Gadolinium contrast agents for CNS imaging: current concepts and clinical evidence.
Kanal E; Maravilla K; Rowley HA
AJNR Am J Neuroradiol; 2014 Dec; 35(12):2215-26. PubMed ID: 24852287
[TBL] [Abstract][Full Text] [Related]
11. 3.0-T whole-heart coronary magnetic resonance angiography: comparison of gadobenate dimeglumine and gadofosveset trisodium.
Raman FS; Nacif MS; Cater G; Gai N; Jones J; Li D; Sibley CT; Liu S; Bluemke DA
Int J Cardiovasc Imaging; 2013 Jun; 29(5):1085-94. PubMed ID: 23515949
[TBL] [Abstract][Full Text] [Related]
12. Safety and adverse effects during 24 hours after contrast-enhanced MRI with gadobenate dimeglumine (MultiHance) in children.
Schneider G; Schürholz H; Kirchin MA; Bücker A; Fries P
Pediatr Radiol; 2013 Jan; 43(2):202-11. PubMed ID: 23179483
[TBL] [Abstract][Full Text] [Related]
13. Multicenter, intraindividual comparison of single-dose gadobenate dimeglumine and double-dose gadopentetate dimeglumine for MR angiography of the supra-aortic arteries (the Supra-Aortic VALUE study).
Li Y; Li X; Li D; Lu J; Xing X; Yan F; Li Y; Wang X; Iezzi R; De Cobelli F
AJNR Am J Neuroradiol; 2013 Apr; 34(4):847-54. PubMed ID: 23042922
[TBL] [Abstract][Full Text] [Related]
14. Comparison of gadobenate dimeglumine and gadodiamide in the evaluation of spinal vascular anatomy with MR angiography.
Spampinato MV; Nguyen SA; Rumboldt Z
AJNR Am J Neuroradiol; 2010 Jun; 31(6):1151-6. PubMed ID: 20053811
[TBL] [Abstract][Full Text] [Related]
15. New dual mode gadolinium nanoparticle contrast agent for magnetic resonance imaging.
Ghaghada KB; Ravoori M; Sabapathy D; Bankson J; Kundra V; Annapragada A
PLoS One; 2009 Oct; 4(10):e7628. PubMed ID: 19893616
[TBL] [Abstract][Full Text] [Related]
16. Contrast-enhanced MR imaging of brain lesions: a large-scale intraindividual crossover comparison of gadobenate dimeglumine versus gadodiamide.
Rowley HA; Scialfa G; Gao PY; Maldjian JA; Hassell D; Kuhn MJ; Wippold FJ; Gallucci M; Bowen BC; Schmalfuss IM; Ruscalleda J; Bastianello S; Colosimo C
AJNR Am J Neuroradiol; 2008 Oct; 29(9):1684-91. PubMed ID: 18599575
[TBL] [Abstract][Full Text] [Related]
17. Follow-up of coiled cerebral aneurysms at 3T: comparison of 3D time-of-flight MR angiography and contrast-enhanced MR angiography.
Anzalone N; Scomazzoni F; Cirillo M; Righi C; Simionato F; Cadioli M; Iadanza A; Kirchin MA; Scotti G
AJNR Am J Neuroradiol; 2008 Sep; 29(8):1530-6. PubMed ID: 18556359
[TBL] [Abstract][Full Text] [Related]
18. [CTA and MRA in peripheral arterial disease--is DSA out?].
Leibecke T; Kagel C; Lubienski A; Peters SO; Jungbluth T; Helmberger T
Radiologe; 2006 Nov; 46(11):941-7. PubMed ID: 17021910
[TBL] [Abstract][Full Text] [Related]
19. [Contrast agents in MRT. Substance, effects, pharmacology and validity].
Reimer P; Vosshenrich R
Radiologe; 2004 Mar; 44(3):273-83. PubMed ID: 15287365
[TBL] [Abstract][Full Text] [Related]
20. Gadobenate dimeglumine (MultiHance) for magnetic resonance angiography: review of the literature.
Goyen M; Debatin JF
Eur Radiol; 2003 Nov; 13 Suppl 3():N19-27. PubMed ID: 15015877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
